Improved Dosing and Administration of Rivaroxaban when Prescribed by a Cardiologist

Rivaroxaban is a direct oral anticoagulant (DOAC) indicated to reduce risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation (AF). A discrepancy exists between the recommended dosage and real-world use of DOACs, especially rivaroxaban, thus putting patients at risk of...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Heart international 2019-01, Vol.13 (1), p.24-27
Hauptverfasser:	Leiter, Madeline R, Packard, Kathleen A, Qi, Yongyue, Krueger, Steven K
Format:	Artikel
Sprache:	eng
Schlagworte:	Anticoagulants Cardiac arrhythmia Cardiology Cardiovascular disease Drug administration Drug dosages Prescription drugs
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!